Total Payments
$14,106
2024 Payments
$1,315
Companies
49
Transactions
654
Medicare Patients
40,484
Medicare Billing
$1.9M
Payment Breakdown by Category
Food & Beverage$13,941 (98.8%)
Education$165.62 (1.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,941 | 646 | 98.8% |
| Education | $165.62 | 8 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,680 | 82 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,419 | 53 | $0 (2024) |
| Amgen Inc. | $1,289 | 58 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,237 | 53 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,118 | 59 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,118 | 45 | $0 (2024) |
| Daiichi Sankyo Inc. | $634.13 | 33 | $0 (2024) |
| Gilead Sciences, Inc. | $532.07 | 35 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $515.57 | 34 | $0 (2024) |
| Esperion Therapeutics, Inc. | $481.21 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,315 | 57 | Novo Nordisk Inc ($174.37) |
| 2023 | $1,749 | 70 | E.R. Squibb & Sons, L.L.C. ($212.90) |
| 2022 | $1,553 | 76 | Bayer HealthCare Pharmaceuticals Inc. ($179.05) |
| 2021 | $2,009 | 91 | Esperion Therapeutics, Inc. ($258.67) |
| 2020 | $890.94 | 47 | Amgen Inc. ($203.59) |
| 2019 | $2,291 | 92 | Janssen Pharmaceuticals, Inc ($385.85) |
| 2018 | $1,781 | 97 | PFIZER INC. ($360.62) |
| 2017 | $2,518 | 124 | PFIZER INC. ($382.09) |
All Payment Transactions
654 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: DIABETES | ||||||
| 11/27/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $21.31 | General |
| Category: Coronary | ||||||
| 11/05/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $44.39 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/03/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/23/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Cardiology | ||||||
| 09/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $124.78 | General |
| 09/11/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: VACCINES | ||||||
| 09/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: DIABETES | ||||||
| 08/27/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: Not Applicable | ||||||
| 08/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Obesity | ||||||
| 08/05/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $27.02 | General |
| Category: Iron Deficiency Anemia | ||||||
| 07/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: DIABETES | ||||||
| 07/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/24/2024 | MEDICOMP INC | TELEPATCH CARDIAC MONITOR (Device) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: CARDIOLOGY | ||||||
| 07/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.27 | General |
| Category: Cardiovascular | ||||||
| 06/12/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $29.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 39 | 10,910 | 14,399 | $1.7M | $550,593 |
| 2022 | 37 | 11,531 | 15,100 | $1.6M | $511,411 |
| 2021 | 37 | 10,417 | 14,554 | $1.4M | $501,394 |
| 2020 | 37 | 7,626 | 10,398 | $1.0M | $380,662 |
Total Patients
40,484
Total Services
54,451
Medicare Billing
$1.9M
Procedure Codes
150
All Medicare Procedures & Services
150 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 696 | 1,014 | $177,450 | $102,192 | 57.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 210 | 212 | $254,400 | $87,358 | 34.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 820 | 1,181 | $135,815 | $79,354 | 58.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 403 | 432 | $332,640 | $75,328 | 22.6% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 50 | 50 | $60,000 | $40,331 | 67.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 1,078 | 1,627 | $138,295 | $18,788 | 13.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 1,010 | 1,684 | $25,260 | $14,078 | 55.7% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 105 | 420 | $16,387 | $12,343 | 75.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 737 | 941 | $47,050 | $12,323 | 26.2% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 210 | 214 | $15,768 | $12,300 | 78.0% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 214 | 217 | $92,225 | $12,191 | 13.2% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 51 | 51 | $42,075 | $9,673 | 23.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 71 | 71 | $14,200 | $9,598 | 67.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 410 | 465 | $23,250 | $7,654 | 32.9% |
| 80076 | Liver function blood test panel | Office | 2023 | 611 | 771 | $23,130 | $6,175 | 26.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 37 | 39 | $8,385 | $5,772 | 68.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 379 | 438 | $99,815 | $4,162 | 4.2% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 409 | 464 | $18,560 | $4,102 | 22.1% |
| 80051 | Blood test panel for electrolytes (sodium potassium, chloride, carbon dioxide) | Office | 2023 | 461 | 570 | $14,250 | $3,910 | 27.4% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 93 | 146 | $14,600 | $3,645 | 25.0% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 374 | 412 | $12,360 | $3,415 | 27.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 369 | 404 | $10,100 | $3,074 | 30.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 12 | 12 | $3,960 | $2,988 | 75.5% |
| 82565 | Blood creatinine level | Office | 2023 | 458 | 571 | $11,420 | $2,859 | 25.0% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 127 | 127 | $7,620 | $2,403 | 31.5% |
About Dr. Joseph Vassallo, M.D
Dr. Joseph Vassallo, M.D is a Cardiovascular Disease healthcare provider based in Chevy Chase, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1932106846.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Vassallo, M.D has received a total of $14,106 in payments from pharmaceutical and medical device companies, with $1,315 received in 2024. These payments were reported across 654 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($13,941).
As a Medicare-enrolled provider, Vassallo has provided services to 40,484 Medicare beneficiaries, totaling 54,451 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 150 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Chevy Chase, MD
- Active Since 07/07/2005
- Last Updated 03/04/2008
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1932106846
Products in Payments
- ELIQUIS (Drug) $1,888
- XARELTO (Drug) $1,419
- JARDIANCE (Drug) $979.19
- ENTRESTO (Drug) $731.87
- Repatha (Biological) $655.97
- Corlanor (Drug) $623.36
- INJECTAFER (Drug) $577.84
- Vascepa (Drug) $433.33
- LEQVIO (Drug) $386.57
- NEXLETOL (Drug) $356.27
- WATCHMAN (Device) $306.13
- Verquvo (Drug) $305.49
- PRALUENT (Drug) $296.59
- CHANTIX (Drug) $296.57
- Ozempic (Drug) $262.60
- BRILINTA (Drug) $241.89
- MULTAQ (Drug) $218.98
- CAMZYOS (Drug) $210.44
- VERQUVO (Drug) $188.96
- Arcalyst (Drug) $160.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Chevy Chase
Dr. Richard Rubin, M.d, M.D
Cardiovascular Disease — Payments: $65,902
Cardiovascular Disease $65,902
Dr. Ankit Shah, M.d., M.p.h, M.D., M.P.H
Cardiovascular Disease — Payments: $30,739
Cardiovascular Disease $30,739
Dr. Jack Flyer, M.d, M.D
Cardiovascular Disease — Payments: $19,663
Cardiovascular Disease $19,663
Dr. Robert Marshall, M.d, M.D
Cardiovascular Disease — Payments: $15,320
Cardiovascular Disease $15,320
Barry Talesnick, M.d, M.D
Cardiovascular Disease — Payments: $14,217
Cardiovascular Disease $14,217
Sean Dwyer, M.d, M.D
Cardiovascular Disease — Payments: $9,280
Cardiovascular Disease $9,280